Conditions: Bacterial Conjunctivitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 474
Healthy volunteers: no

Brief summary:
This study is being conducted to evaluate the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle in the treatment of bacterial conjunctivitis. This study was conducted as a phase IIb study and continued with further enrollment as a phase III study.

Detailed description:

Arms:
arm 1: 0.6% ophthalmic suspension arm 2: None

Interventions: intervention 1: Besifloxacin intervention 2: Vehicle (Placebo)
Intervention descriptions: intervention 1: Besifloxacin 0.6% administered into the study eye two times a day for three days. intervention 2: Vehicle administered to the study eye two times a day for three days.

Protocol document: